Yun‐Wei Lin

2.4k total citations
82 papers, 1.9k citations indexed

About

Yun‐Wei Lin is a scholar working on Molecular Biology, Oncology and Computer Networks and Communications. According to data from OpenAlex, Yun‐Wei Lin has authored 82 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 20 papers in Oncology and 13 papers in Computer Networks and Communications. Recurrent topics in Yun‐Wei Lin's work include DNA Repair Mechanisms (16 papers), Cancer therapeutics and mechanisms (13 papers) and Heat shock proteins research (10 papers). Yun‐Wei Lin is often cited by papers focused on DNA Repair Mechanisms (16 papers), Cancer therapeutics and mechanisms (13 papers) and Heat shock proteins research (10 papers). Yun‐Wei Lin collaborates with scholars based in Taiwan, United States and China. Yun‐Wei Lin's co-authors include Jia‐Ling Yang, Yuh‐Shyan Chen, Show‐Mei Chuang, Jen‐Chung Ko, Min‐Shao Tsai, Yi‐Bing Lin, Shao‐Hsing Weng, Pin Ju Chueh, Tung‐Sheng Shih and Szu‐Ting Lin and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Yun‐Wei Lin

82 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yun‐Wei Lin Taiwan 25 870 338 292 258 242 82 1.9k
Thomas Wiese United States 27 795 0.9× 190 0.6× 131 0.4× 210 0.8× 64 0.3× 59 2.0k
György Tibor Balogh Hungary 25 468 0.5× 107 0.3× 101 0.3× 425 1.6× 442 1.8× 139 2.5k
Li‐Ping Bai China 30 1.2k 1.4× 110 0.3× 554 1.9× 124 0.5× 21 0.1× 171 3.4k
Yunjie Zhao China 34 2.3k 2.6× 211 0.6× 98 0.3× 174 0.7× 135 0.6× 150 4.3k
Xianqin Wang China 23 726 0.8× 123 0.4× 230 0.8× 97 0.4× 26 0.1× 160 2.1k
Tao Ye China 33 1.1k 1.3× 192 0.6× 53 0.2× 157 0.6× 19 0.1× 132 4.1k
Ningbo Zhang China 23 880 1.0× 73 0.2× 384 1.3× 623 2.4× 195 0.8× 141 2.4k
Jiang Zheng China 27 1.4k 1.6× 213 0.6× 291 1.0× 29 0.1× 87 0.4× 187 3.2k
Junyan Ma China 24 530 0.6× 79 0.2× 69 0.2× 348 1.3× 79 0.3× 113 2.0k
Kwang‐Il Park South Korea 27 816 0.9× 113 0.3× 286 1.0× 283 1.1× 84 0.3× 128 2.1k

Countries citing papers authored by Yun‐Wei Lin

Since Specialization
Citations

This map shows the geographic impact of Yun‐Wei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun‐Wei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun‐Wei Lin more than expected).

Fields of papers citing papers by Yun‐Wei Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun‐Wei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun‐Wei Lin. The network helps show where Yun‐Wei Lin may publish in the future.

Co-authorship network of co-authors of Yun‐Wei Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yun‐Wei Lin. A scholar is included among the top collaborators of Yun‐Wei Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun‐Wei Lin. Yun‐Wei Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Yun‐Wei, et al.. (2024). Watermelons Talk: Predicting Ripeness through Tapping. IEEE Internet of Things Magazine. 7(4). 154–161. 1 indexed citations
4.
Lin, Yun‐Wei, et al.. (2018). AItalk: a tutorial to implement AI as IoT devices. IET Networks. 8(3). 195–202. 24 indexed citations
5.
Tung, Chun‐Liang, Jyh‐Cheng Chen, Chia-Hung Wu, et al.. (2017). Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cells. Experimental Cell Research. 357(1). 59–66. 9 indexed citations
6.
Wei, Chia-Li, Jyh‐Cheng Chen, Hao‐Yu Zheng, et al.. (2016). Astaxanthin enhances pemetrexed-induced cytotoxicity by downregulation of thymidylate synthase expression in human lung cancer cells. Regulatory Toxicology and Pharmacology. 81. 353–361. 22 indexed citations
7.
Ko, Jen‐Chung, Po‐Yuan Chang, Jyh‐Cheng Chen, et al.. (2015). Minocycline enhances mitomycin C-induced cytotoxicity through down-regulating ERK1/2-mediated Rad51 expression in human non-small cell lung cancer cells. Biochemical Pharmacology. 97(3). 331–340. 8 indexed citations
8.
Lin, Yun‐Wei, et al.. (2014). Broadband planar magic-T with Marchand type power divider and balun. Asia-Pacific Microwave Conference. 94–96. 3 indexed citations
9.
Tung, Chun‐Liang, et al.. (2014). Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells. Experimental Cell Research. 322(2). 345–354. 19 indexed citations
12.
Ko, Jen‐Chung, Yu‐Ching Huang, Shao‐Hsing Weng, et al.. (2012). HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells. Regulatory Toxicology and Pharmacology. 64(3). 415–424. 20 indexed citations
13.
Tsai, Min‐Shao, et al.. (2011). Inhibition of p38 MAPK-Dependent Excision Repair Cross-Complementing 1 Expression Decreases the DNA Repair Capacity to Sensitize Lung Cancer Cells to Etoposide. Molecular Cancer Therapeutics. 11(3). 561–571. 31 indexed citations
14.
Tsai, Min‐Shao, et al.. (2010). Down-Regulation of Rad51 Expression Overcomes Drug Resistance to Gemcitabine in Human Non–Small-Cell Lung Cancer Cells. Journal of Pharmacology and Experimental Therapeutics. 335(3). 830–840. 63 indexed citations
15.
Ko, Jen‐Chung, Shih‐Ci Ciou, Chao‐Min Cheng, et al.. (2009). Roles of MKK1/2-ERK1/2 and Phosphoinositide 3-Kinase–AKT Signaling Pathways in Erlotinib-Induced Rad51 Suppression and Cytotoxicity in Human Non–Small Cell Lung Cancer Cells. Molecular Cancer Research. 7(8). 1378–1389. 38 indexed citations
17.
Chen, Ruey-Shyang, Ying-Jhen Su, Wei‐Ting Lee, et al.. (2009). Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation. Experimental Cell Research. 315(15). 2658–2672. 26 indexed citations
18.
Ko, Jen‐Chung, Ying-Jhen Su, Szu‐Ting Lin, et al.. (2009). Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells. Biochemical Pharmacology. 79(4). 655–664. 63 indexed citations
19.
Ko, Jen‐Chung, et al.. (2009). The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells. Lung Cancer. 65(3). 290–298. 9 indexed citations
20.
Ko, Jen‐Chung, et al.. (2008). Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells. Molecular Cancer Therapeutics. 7(11). 3632–3641. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026